Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene

EU orphan designation number: EU/3/10/767   
Active ingredient: 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
Indication: Treatment of post-essential thrombocythaemia myelofibrosis
Sponsor: Baxter Innovations GmbH
Industriestraße 67, A-1221 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/08/2010 Orphan Designation EMA/OD/058/10 (2010)5965 of 25/08/2010
23/03/2015 Transfer of orphan designation EMA/OD/058/10/T/01 (2015)2042 of 19/03/2015